Acura Pharma Stock Price (NASDAQ:ACUR)

Add to My Stocks
$0.6 $0.03 (5.26%) ACUR stock closing price Jan 20, 2017 (Closing)
Prev Close* : $0.57
Market Cap:
$6.69M
Day Low: $0.51
52 Week Low: $0.51
Open: $0.57
Volume: 93154
Day High: $0.6
52 Week High: $3.52
Dividend:
N/A

Latest Stock Market News

Latest Articles

Acura Pharma News - From Partners

ACUR Stockcharts

View ACUR PE ratio, PS ratio stocks charts and compare with peers.
ACUR Chart
Note: Compare Acura Pharma stock price history with the index and industry peers.

Acura Pharma Valuation

PS ratio (
price to sales ratio
)
2.11
PB ratio (
price to book ratio
)
1.58

Acura Pharma Financial Ratios

Asset Turnover
0.1
Receivables Turnover
22.53

ACUR Industry Peers

Company Price Change (%)
Acasti Pharma (ACST)1.260 (0%)
China Pharma (CPHI)0.270 (0%)
Egalet (EGLT)5.020.22 (4.2%)
Kempharma (KMPH)3.250.05 (1.52%)
Pain Therapeutics (PTIE)0.580.02 (3.57%)
Nektar Therapeutics (NKTR)12.020.23 (1.88%)
Collegium Pharma (COLL)14.950.19 (1.29%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Teligent (TLGT)6.80.17 (2.56%)
Dr. Reddy's Laboratories (RDY)43.50.3 (0.69%)
Mylan (MYL)37.070.12 (0.32%)
Top gainers from Medical-Generic Drugs industry
* As of Jan 21, 2017
CompanyPriceChange (%)
Mallinckrodt (MNK)46.082.04 (4.24%)
Aquinox Pharma (AQXP)17.470.5 (2.78%)
Adamas Pharma (ADMS)16.170.25 (1.52%)
AxoGen (AXGN)9.80.1 (1.01%)
Teva Pharmaceutical (TEVA)33.230.24 (0.72%)
Akorn (AKRX)20.520.09 (0.44%)
AEVI GENOMIC (GNMX)4.90.02 (0.41%)
Top losers from Medical-Generic Drugs industry
* As of Jan 21, 2017

Acura Pharma Financial Statements

income statement20152014201320122011
Net Sales Or Revenues8.58M0.75M0.12M-20.46M
Net Income-4.98M-13.2M-13.9M-9.66M10.38M
Total Operating Expense11.92M12.72M14.09M9.73M9.92M
view Acura Pharmaceuticals, Inc. income statement
balance sheet20152014201320122011
Total Assets16.96M16.19M28.63M29.05M37.17M
Total Liabilities9.06M11.14M10.7M1.42M0.53M
Shareholders Equity7.9M5.05M17.92M27.63M36.64M
view Acura Pharmaceuticals, Inc. balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities-0.56M0.36M-1.37M0.75M-0.67M
Net Cash From (Used By) Operating Activities-3.68M-11.04M-13.67M-7.03M12.31M
Increase (Decrease) In Prop Plant And Equipment-0.2M-0.13M-0.02M-0.14M-0.13M
view Acura Pharmaceuticals, Inc. cashflow statement

Acura Pharmaceuticals, Inc. Stock News - Partner Headlines

Acura Pharma Stock Message Board

As of last trading day, Acura Pharma stock price was 0.6. The total market value as denoted by 6.69M for Acura Pharma, is the market value of the company's outstanding shares. A value investor must look at the fundamentals of a stock, and perform Acura Pharma valuation, even though in the short-term sentiment and current breaking news might affect Acura Pharma stock price.

For recognizing and analyzing the real performance of Acura Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 93154 ACUR shares were traded yesterday, and Acura Pharma stock chart shows that the ACUR stock quote hit a day high of 0.6 and day low of 0.51. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Acura Pharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.